S'abonner navigation icon
FR
navigation icon menu icon S'abonner
navigation icon Accueil navigation icon Catalogue
icon language Langues navigation icon Menu
icon close
icon arrow

Rechercher

icon searchbar

Rechercher

Catalogue

icon close
icon close
icon close
icon language

Langues

icon close
background image
button download
icon share social
Category Takeda s New Investigational Drug Vedolizumab Entered Phase 3 Clinical Trials in Japan For the Treatment of Ulcerative Colitis and Crohn s Disease
Lire
Lire

Takeda's New Investigational Drug Vedolizumab Entered Phase 3 Clinical Trials in Japan For the Treatment of Ulcerative Colitis and Crohn's Disease

  • 4

    pages

  • English

  • Documents

  • 2014

Publié par
icon arrow

  • 4

    pages

  • English

  • Documents

  • 2014

Lire
Lire
icon

Description

Takeda's New Investigational DrugTakeda's New Investigational Drug Vedolizumab Entered Phase 3 Clinical Trials in Japan For the Treatment of Ulcerative Colitis and Crohn's Disease PR Newswire OSAKA, Japan, Jan.
Voir icon arrow
icon success

Ajouté à mes notifications

Vous serez informé des prochaines publications.